These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38173145)

  • 21. A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations.
    Daoui O; Nour H; Abchir O; Elkhattabi S; Bakhouch M; Chtita S
    J Biomol Struct Dyn; 2023; 41(16):7768-7785. PubMed ID: 36120976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques.
    Tabti K; Baammi S; Sbai A; Maghat H; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2023; 41(23):13798-13814. PubMed ID: 36841617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
    Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
    Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and screening of FAK, CDK 4/6 dual inhibitors by pharmacophore model, molecular docking, and molecular dynamics simulation.
    Sun C; Feng L; Sun X; Yu R; Kang C
    J Biomol Struct Dyn; 2021 Sep; 39(15):5358-5367. PubMed ID: 32627678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the structural requirements of triazole derivatives as promising DPP IV inhibitors: computational investigations.
    Shah BM; Sagar SR; Trivedi P
    J Biomol Struct Dyn; 2022; 40(24):13778-13798. PubMed ID: 34738504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
    Zhong W; Liu P; Zhang Q; Li D; Lin J
    J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations.
    Xu C; Ren Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4522-8. PubMed ID: 26343829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D-QSAR modeling and molecular docking studies on a series of 2, 4, 5-trisubstituted imidazole derivatives as CK2 inhibitors.
    Goudzal A; El Aissouq A; El Hamdani H; Hadaji EG; Ouammou A; Bouachrine M
    J Biomol Struct Dyn; 2023 Jan; 41(1):234-248. PubMed ID: 35068344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.
    Faris A; Ibrahim IM; Alnajjar R; Hadni H; Bhat MA; Yaseen M; Chakraborty S; Alsakhen N; Shamkh IM; Mabood F; M Naglah A; Ullah I; Ziedan N; Elhallaoui M
    J Biomol Struct Dyn; 2023 Dec; ():1-30. PubMed ID: 38059345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D-QSAR, molecular docking, and molecular dynamics analysis of dihydrodiazaindolone derivatives as PARP-1 inhibitors.
    Zhao J; Yu N; Zhao X; Quan W; Shu M
    J Mol Model; 2023 Apr; 29(5):131. PubMed ID: 37020092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined machine learning models, docking analysis, ADMET studies and molecular dynamics simulations for the design of novel FAK inhibitors against glioblastoma.
    Zhao Y; He X; Wan Q
    BMC Chem; 2024 Oct; 18(1):203. PubMed ID: 39425154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors.
    Khamouli S; Belaidi S; Ouassaf M; Lanez T; Belaaouad S; Chtita S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1285-1298. PubMed ID: 32964807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations.
    Melge AR; Kumar LG; K P; Nair SV; K M; C GM
    J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational Investigations of Coumarin Derivatives as Cyclindependent Kinase 9 Inhibitors Using 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Liu S; Li Y; Wei X; Zhang R; Zhang Y; Guo C
    Curr Comput Aided Drug Des; 2022; 18(5):363-380. PubMed ID: 35980073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking.
    Ding H; Xing F; Zou L; Zhao L
    BMC Chem; 2024 Mar; 18(1):59. PubMed ID: 38555462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
    Gao Y; Wang H; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-Dimensional-QSAR and Relative Binding Affinity Estimation of Focal Adhesion Kinase Inhibitors.
    Ghosh S; Cho SJ
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies.
    Cabezas D; Mellado G; Espinoza N; Gárate JA; Morales C; Castro-Alvarez A; Matos MJ; Mellado M; Mella J
    J Biomol Struct Dyn; 2023; 41(22):13250-13259. PubMed ID: 36718094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.